Aggressive multimodality treatment for primary malignant peritoneal mesothelioma

ANZ J Surg. 2001 Nov;71(11):683-5. doi: 10.1046/j.1445-1433.2001.02239.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Male
  • Mesothelioma / drug therapy
  • Mesothelioma / surgery
  • Mesothelioma / therapy*
  • Middle Aged
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / surgery
  • Peritoneal Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents